A new international study conducted by the Israeli Phage Therapy Center (IPTC) led by Prof. Ran Nir-Paz at Hadassah Hebrew University Medical Center and Prof. Ronen Hazan of the Faculty of Dental Medicine at The Hebrew University of Jerusalem, using…

New research from the Black Women’s Experiences Living with Lupus (BeWELL) Study has revealed that racial discrimination is a distinct health threat that heightens the risk of disease among Black Americans. The research, focused on Black women with systemic lupus…

In a recent review published in Natures Signal Transduction and Targeted Therapy Journal, a group of authors explored current and future strategies in the design of tumor tissue-, cell-, and organelle-targeted cancer nanomedicines, emphasizing the latest advances in hierarchical targeting…

Dr Hilary lists the early symptoms of dementia Dementia refers to conditions that are characterised by an impaired ability to remember, think, or make decisions that interfere with daily life. Early detection of the mind-robbing condition can buy precious time…

When it’s hot outside, it’s safer to head for air-conditioned shelter—right? Not always. In northern Australia’s intensely hot climate, air conditioners were once luxury items. Houses were built to catch the breeze, and everything slowed down when the hot weather…

Source: Read Full Article

Since the beginning of July all there have been indications that COVID infections are increasing again in the UK. The daily number of new positive tests and the proportion of tests coming back positive have been increasing since the end…

The 2023 State of Cybersecurity for Medical Devices and Healthcare Systems report, a collaboration of the Health Information Sharing and Analysis Center with Securin and Finite State, examined the critical and high-rated vulnerabilities that put the underpinning software and firmware…

Blood disorders known as myelodysplastic syndromes/neoplasms (MDS) are difficult to diagnose—and are commonly misdiagnosed—putting patients at increased risk for treatment mistakes and other potentially harmful consequences, according to researchers with Sylvester Comprehensive Cancer Center at the University of Miami Miller…

(Reuters) – Organon & Co reported better-than-expected second-quarter results on Tuesday, helped by strong demand for its women’s heath products and biosimilar drugs, sending the healthcare firm’s shares up about 8%. The company posted quarterly revenue of $1.61 billion, beating…